How to Buy Amphastar Pharmaceuticals Stock
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals, Inc. , a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
Amphastar Pharmaceuticals stock last closed at $45.38, down 0.09% from the previous day, and has decreased 12.78% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.25 percentage points. Amphastar Pharmaceuticals stock is currently +24.12% from its 52-week low of $36.56, and -31.16% from its 52-week high of $65.93.
As of Sep 6, 2024, there are 48.68M shares of AMPH outstanding. The market capitalization of AMPH is $2.21B. In the last 24 hours, 239,076 AMPH shares were traded.
How to Buy Amphastar Pharmaceuticals Stock
Not sure how to invest in Amphastar Pharmaceuticals stock? Here's how.
- Decide where to buy Amphastar Pharmaceuticals stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you choose where to buy Amphastar Pharmaceuticals stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Fund your investment account: Choose your method of payment and add your info.
- Evaluate Amphastar Pharmaceuticals stock: The Amphastar Pharmaceuticals ticker symbol is AMPH. Is Amphastar Pharmaceuticals stock a good investment? Should you buy shares of AMPH? How do AMPH's underlying business fundamentals look? Do top analysts think Amphastar Pharmaceuticals is a good buy? Why has AMPH's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if AMPH is a good stock to buy).
- Execute your AMPH buy order: Decide if you will purchase AMPH shares at the current market price or use a limit order to purchase AMPH shares at a specific price.
- Keep an eye on your AMPH position: Create a watchlist to keep tabs on your new investment in Amphastar Pharmaceuticals shares.
Step 1: Decide where to buy Amphastar Pharmaceuticals stock
You need a brokerage account in order to access the NASDAQ market and buy AMPH shares.
Our favorite brokerage: eToro
Based on our research, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world financial markets: From Technology to Energy, New York to Tokyo — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by creating an account with eToro now.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen your brokerage, the next step is to fill out some personal information so you can buy AMPH stock today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to create a new trading account.
- Submit your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you've opened your account on a investment app, you can securely and quickly fund your account:
Watch the walkthrough below for more details depositing funds into your brokerage account.
Step 4: Evaluate Amphastar Pharmaceuticals stock
Once you have figured out the best place to buy Amphastar Pharmaceuticals stock, it's important to analyze their stock before you invest, so you actually wrap your head around the risk and upside.
Amphastar Pharmaceuticals stock data
Amphastar Pharmaceuticals Overview
WallStreetZen was designed to help part-time investors do better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on AMPH's stock page.
Is AMPH stock undervalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge AMPH's fair value.
Using relative valuations measures:
- AMPH could be undervalued based on its P/E ratio of 13.23x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of 20.57x
- AMPH could be overvalued based on its P/B ratio of 3.1x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.28x
- AMPH may be undervalued based on its PEG ratio of 0.71x
You can access more valuation analysis on AMPH's stock here.
A quick look at AMPH Financials
Passed Health Checks:
- AMPH profit margin has gone up from 18.8% to 23.4% in the past year.
- AMPH earnings of $242.01M is not sufficient to cover its interest payments.
- There are more short-term assets than short-term liabilities on the AMPH balance sheet.
- AMPH's operating cash flow of $212.60M allows it to safely service it's debt of $620.58M.
Failed Health Checks:
- AMPH has a relatively high debt to equity ratio of 1.09.
- There are more long-term liabilities than short-term assets on the AMPH balance sheet.
- Total AMPH debt is higher than 5 years ago, relative to shareholder equity.
Is it a good time to buy AMPH stock, according to Wall Street analysts?
Out of 1 Equities analysts who track AMPH, the consensus analyst rating on Amphastar Pharmaceuticals is a Strong Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Amphastar Pharmaceuticals stock forecast page.
AMPH Momentum
AMPH Growth Numbers
Last year, AMPH earnings were $166.52M. In the last 5 year, AMPH's earnings have increased by 25.09% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 11.23%.
Last year, AMPH revenue was $712.89M. During the past 5 year, AMPH's revenue has increased by 17.08% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 19.57%.
Dive into AMPH's earnings and revenue performance here.
What are AMPH insiders up to?
In the last 12 months, insiders at AMPH have bought more shares than they have sold.
Floyd F. Petersen, Director of AMPH, was the latest AMPH insider to sell. They sold $139,416.00 worth of AMPH shares on Sep 5, 2024.
Get more info about who owns AMPH stock here.
Can I get consistent income from AMPH stock?
No, Amphastar Pharmaceuticals doesn't provide an income stream by paying out dividends.
AMPH Social Trading Data
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your AMPH buy order
There are two main options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly sufficient. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at an exact price limit, use a limit order.
Click the Open Trade button and eToro will place your order.
If you need more info about investing in stocks on eToro, click the helpful video below:
Step 6: Keep an eye on your AMPH position
Now that you own some AMPH shares, you'll want to stay up-to-date on your stock purchase.
Add AMPH to a watchlist to get the latest updates about your AMPH stock.
AMPH Feed
How to Buy Stock in Amphastar Pharmaceuticals
To summarize, here are the 6 steps you need to take to buy Amphastar Pharmaceuticals stock right now:
- Decide where to buy Amphastar Pharmaceuticals stock
- Sign up for a brokerage account
- Fund your investment account
- Evaluate Amphastar Pharmaceuticals stock
- Execute your AMPH buy order
- Keep an eye on your AMPH position
If you require a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get updates on your investment in Amphastar Pharmaceuticals, click below.
More "How To" Guides You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.